Austrian recommendations for the management of essential thrombocythemia.

Buxhofer-Ausch, V; Heibl, S; Sliwa, T; Beham-Schmid, C; Wolf, D; Geissler, K; Krauth, MT; Krippl, P; Petzer, A; Wolfler, A; Melchardt, T; Gisslinger, H. Wien Klin Wochenschr. 2021 Jan;133(1-2):52-61. doi: 10.1007/s00508-020-01761-3. Epub 2020 Nov 19.

Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.

Heregger, R; Huemer, F; Hutarew, G; Hecht, S; Cheveresan, L; Kotzot, D; Schamschula, E; Rinnerthaler, G; Melchardt, T; Weiss, L; Greil, R. ESMO Open. 2021 Aug;6(4):100233. doi: 10.1016/j.esmoop.2021.100233. Epub 2021 Aug 7.

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.

Magnes, T; Wagner, S; Kiem, D; Weiss, L; Rinnerthaler, G; Greil, R; Melchardt, T. Int J Mol Sci. 2021 May 7;22(9):4981. doi: 10.3390/ijms22094981.

Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial.

Keil, F; Hartl, M; Altorjai, G; Berghold, A; Riedl, R; Pecherstorfer, M; Mayrbäurl, B; De Vries, A; Schuster, J; Hackl, J; Füreder, T; Melchardt, T; Burian, M; Greil, R. Eur J Cancer. 2021 Jul;151:201-210. doi: 10.1016/j.ejca.2021.03.051. Epub 2021 May 19.

SAMHD1 restrains aberrant nucleotide insertions at repair junctions generated by DNA end joining.

Akimova, E; Gassner, FJ; Schubert, M; Rebhandl, S; Arzt, C; Rauscher, S; Tober, V; Zaborsky, N; Greil, R; Geisberger, R. Nucleic Acids Res. 2021 Mar 18;49(5):2598-2608. doi: 10.1093/nar/gkab051.

Cytotoxic constituents and a new hydroxycinnamic acid derivative from Leontodon saxatilis (Asteraceae, Cichorieae).

Cicek, SS; Willer, J; Preziuso, F; Sonnichsen, F; Greil, R; Girreser, U; Zidorn, C; Johrer, K. RSC ADV. 2021; 11(18): 10489-10496. DOI: 10.1039/d0ra10973h

Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchro-nous Biopsies.

Magnes, T; Wagner, S; Thorner, AR; Neureiter, D; Klieser, E; Rinnerthaler, G; Weiss, L; Huemer, F; Schlick, K; Zaborsky, N; Steiner, M; Greil, R; Egle, A; Melchardt, T. Cancers (Basel). 2021 Feb 6;13(4):650. doi: 10.3390/cancers13040650.

Overcoming negative predictions of microRNA expressions to gemcita-bine response with FOLFIRINOX in advanced pancreatic cancer patients.

Schlick, K; Hohla, F; Hamacher, F; Hackl, H; Hufnagl, C; Markus, S; Magnes, T; Gampenrieder, SP; Melchardt, T; Stattner, S; Hauser-Kronberger, C; Greil, R; Rinnerthaler, G. Future Sci OA. 2020 Nov 30;7(2):FSO644. doi: 10.2144/fsoa-2020-0128.

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.

Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P. Support Care Cancer. 2021 Feb 24. doi: 10.1007/s00520-021-06059-2. Online ahead of print.

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors.

Huemer, F; Leisch, M; Geisberger, R; Zaborsky, N; Greil, R. Pharmaceuticals (Basel). 2021 Jan 26;14(2):89. doi: 10.3390/ph14020089.